Adaptive Biotechnologies CorporationADPTNASDAQ
Loading
R&D Expenses Over TimeStable
Percentile Rank38
3Y CAGR-12.9%
5Y CAGR-4.2%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-12.9%/yr
vs +37.9%/yr prior
5Y CAGR
-4.2%/yr
Recent deceleration
Acceleration
-50.8pp
Decelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
4 yr
Consecutive declineStable
PeriodValueYoY Change
2025$93.77M-8.9%
2024$102.95M-15.7%
2023$122.12M-13.9%
2022$141.76M-0.4%
2021$142.34M+22.6%
2020$116.07M+64.2%
2019$70.70M+80.6%
2018$39.16M+22.4%
2017$32.00M-